This Guideline supersedes the previous version 6 of Guideline UST-21 as of 01 April 2021.
The Guideline is published on the basis of and in compliance with the provision of Section 102(1) of Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (Act on Pharmaceuticals), as amended.
The Guideline is legally binding.
Annexes: